Urinary Tract & Kidneys

PROMICEF TAZO is a broad-spectrum veterinary antibiotic therapy designed for dogs and cats, formulated with a powerful combination of Ceftriaxone (third-generation cephalosporin) and Tazobactam (beta-lactamase inhibitor). This synergistic blend enhances antibacterial efficacy against resistant organisms, making it highly effective in the treatment of complex systemic and localized infections. Ceftriaxone inhibits bacterial cell wall synthesis by binding to essential enzymes (PBPs), leading to bacterial lysis, while Tazobactam protects ceftriaxone from degradation by beta-lactamase enzymes, thereby extending its spectrum of activity. This injection provides reliable therapeutic outcomes in respiratory, dermatological, urinary, bone and joint, intra-abdominal, and systemic infections, ensuring optimal veterinary care.(Reviewed and presented by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ, exclusively on PᴇᴛsLɪғᴇsᴛʏʟᴇ.) Composition Each combipack contains: 1 Vial of PROMICEF TAZO Ceftriaxone Sodium IP (Sterile), eq. to Anhydrous Ceftriaxone – 500 mg Tazobactam Sodium IP (Sterile), eq. to Tazobactam – 62.5 mg 1 Ampoule of Sterile Water for Injection IP Sterile Water – 5 ml Indications PROMICEF TAZO is indicated for the treatment of bacterial infections caused by resistant organisms in dogs and cats, including: Respiratory tract infections Bacterial skin and soft tissue infections Urinary tract infections Bone and joint infections Septicemia and systemic bacterial infections Intra-abdominal infections Meningitis Benefits Broad-spectrum efficacy against Gram-positive and Gram-negative pathogens Enhanced antibacterial activity due to beta-lactamase inhibition Effective for resistant and complicated infections Suitable for both IV and IM administration in dogs and cats Reliable treatment for both localized and systemic bacterial infections Dosage and Administration Dogs: 15–50 mg/kg every 12–24 hours (IM/IV) Cats: 25–50 mg/kg every 12 hours (IM/IV) Reconstitute before administration: IV use: Dissolve in 5 ml sterile water for injection IM use: Dissolve in 2 ml sterile water for injection Use immediately after preparation or as advised by the veterinarian. Dosage is calculated on ceftriaxone equivalence (500 mg ceftriaxone = 562.5 mg ceftriaxone + tazobactam). Warnings & Precautions Do not use in pets with known hypersensitivity to cephalosporins or tazobactam. For veterinary use only; not for oral administration. Pain may occur at IM injection site; IV use may cause local phlebitis. Monitor liver/kidney function during prolonged use. Avoid concurrent use with aminoglycosides or calcium-containing solutions. Adverse Reactions Gastrointestinal upset (nausea, vomiting, diarrhea) Hematological changes (eosinophilia, thrombocytosis, leucopoenia) Elevated liver enzymes, creatinine, and BUN levels in rare cases False-positive Coombs’ and urine glucose test possible Storage Store below 30°C, protected from light and moisture. Do not freeze. Presentation Vial containing: Ceftriaxone 500 mg + Tazobactam 62.5 mg (powder) Ampoule: 5 ml sterile water for injection Syringe and needle provided in pack Manufacturer SAVA HEALTHCARE LIMITEDPlot No. 507-B to 512, GIDC Estate, Wadhwan City – 363035,Surendranagar, Gujarat, India

Read more less

ACEPTOR® 5 contains Benazepril Hydrochloride (5 mg), a veterinary-grade ACE inhibitor. Once administered, it's converted into benazeprilat, which inhibits angiotensin II formation, leading to vasodilation and reduced aldosterone activity. This makes it an effective choice for managing hypertension, heart failure, and kidney-related conditions in pets.Recommended by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ, available at PᴇᴛsLɪғᴇsᴛʏʟᴇ – BecausePetsDeserveALifestyleToo Use In Dogs: Congestive heart failure (e.g., mitral valve disease, dilated cardiomyopathy) Systemic hypertension Adjunct therapy for chronic kidney disease and protein-losing nephropathy Support for valvular heart disease and left-to-right shunts Cats: Hypertension management Adjunctive therapy in hypertrophic cardiomyopathy Reducing protein loss in chronic renal disease Improving appetite and overall condition in cats with CKD Key Benefits Supports blood pressure reduction and eases cardiac strain Enhances renal perfusion and filtration capabilities Medium-dose formulation is ideal for moderate-weight pets and precise dosing Flexible once- or twice-a-day dosing structure Well tolerated by both dogs and cats under veterinary guidance Dosage & Administration Recommended Dose: 0.25–0.5 mg/kg orally, once or twice daily (follow your vet’s instructions) Example: A 20 kg dog would need 5–10 mg daily, perfectly suited to the 5 mg tablet. Always adhere to your veterinarian’s dosing and schedule recommendations. Warnings & Precautions Contraindicated in animals with known ACE inhibitor hypersensitivity Use cautiously in pets with low sodium, hypotension, or compromised vascular circulation Vigilant monitoring advised in severe heart failure cases or preexisting vascular conditions Not recommended for use during pregnancy unless clearly justified by therapeutic benefits Possible Side Effects Potential hypotension, especially with concurrent diuretic use Risk of renal impact or elevated potassium levels; monitoring is important In feline overdose studies, the only notable outcomes were increased appetite and weight gain Drug Interactions Aspirin: May counter the blood pressure–lowering effects Diuretics (e.g., furosemide): May exacerbate hypotension—dose adjustments might be needed Potassium-sparing agents/supplements: Heightened hyperkalemia risk Insulin/oral antidiabetics: Enhanced hypoglycemia risk—monitor glucose levels Lithium: Increased lithium levels may occur—monitor blood levels carefully Storage Store in a cool (<30 °C), dry, and dark place. Keep away from direct sunlight and moisture. Keep out of reach of children. For veterinary use only — not intended for human consumption. Manufacturer: Sava Healthcare Limited, Gujarat, India

Read more less

ACEPTOR® 2.5 contains Benazepril Hydrochloride (2.5 mg), a potent angiotensin-converting enzyme (ACE) inhibitor used in veterinary medicine. After oral administration, it converts to its active form, benazeprilat, which helps lower blood pressure by inhibiting the formation of angiotensin II—reducing vessel constriction and aldosterone-mediated fluid retention. This makes it especially useful for managing heart and kidney-related conditions.Recommended by Vɪsʜɴᴜ Dᴜᴛᴛ Tʀɪᴘᴀᴛʜɪ | Pᴇᴛ Exᴘᴇʀᴛ, available at PᴇᴛsLɪғᴇsᴛʏʟᴇ – BecausePetsDeserveALifestyleToo Use In Dogs: Congestive heart failure (e.g., mitral valve disease, dilated cardiomyopathy) Hypertension Adjunct therapy in chronic kidney disease and protein-losing nephropathy Supporting treatment in valvular heart conditions or shunts Cats: Systemic hypertension Hypertrophic cardiomyopathy (adjunctive) Reducing proteinuria in chronic kidney disease Enhancing appetite and well-being in renal insufficiency Key Benefits Helps lower blood pressure and reduce strain on the heart Supports kidney function by improving filtration and blood flow Convenient low-dose allows precise adjustment based on weight Once- or twice-daily dosing enhances compliance Generally well-tolerated in both dogs and cats Dosage & Administration Dose: 0.25–0.5 mg/kg orally, once or twice daily (as directed by a vet) Example: A 10-kg dog or cat would require 2.5–5 mg—making the 2.5 mg tablet ideal for dosing flexibility. Follow your veterinarian’s guidance on duration and dosing intervals. Warnings & Precautions Avoid use in animals with known hypersensitivity to ACE inhibitors Use cautiously in cases of sodium depletion, low blood pressure, or compromised blood flow Close monitoring is advised in severe heart failure or pre-existing vascular issues Not recommended during pregnancy unless benefits clearly outweigh risks Possible Side Effects Hypotension, especially if combined with diuretics Renal impairment or elevated potassium levels in susceptible individuals In overdose studies in healthy cats, only increased appetite and weight gain were noted Drug Interactions Aspirin: May reduce beneficial blood vessel dilation Diuretics (e.g., furosemide): Can lead to stronger blood pressure drops—vet may reduce dose Potassium-rich medications/supplements: Increased risk of hyperkalemia Insulin/oral hypoglycemics: Monitor closely for potential hypoglycemia Lithium: May raise lithium blood levels—monitor carefully Storage Keep in a cool, dry place below 30 °C, away from sunlight and moisture. Store out of reach of children. For veterinary use only—not intended for humans. Manufacturer: Sava Healthcare Limited, Gujarat, India 

Read more less

Aceptor is a vasodilator drug that functions primarily by inhibiting the ACE. Vasodilation caused by the action helps in controlling hypertension and decreasing the proteinuria associated with CKD. Composition: BENAZEPRIL HYDROCHLORIDE Class: ACE Inhibitor Indications/Uses  Hypertension                        10mg Dilated Cardiomayopathy      q.s. Directions for use:  Dosage - As recommended by the veterinarian. Net Quantity: 1 strip (10 tablets) Suitable for Dogs and Cats   Benazepril is a medication primarily used to treat: High blood pressure (hypertension) Heart failure Chronic kidney disease (CKD), especially in diabetic patients It belongs to a class of drugs called ACE inhibitors (Angiotensin-Converting Enzyme inhibitors). These work by relaxing blood vessels so blood can flow more easily, reducing the workload on the heart. Common uses: Lowering blood pressure – helps prevent strokes, heart attacks, and kidney problems. Heart failure – improves survival and reduces symptoms like shortness of breath. Kidney protection – particularly useful in slowing kidney damage in people with diabetes or high blood pressure. How it's taken: Usually as an oral tablet, once or twice daily. Sometimes combined with other medications like diuretics. Common side effects: Cough (dry, persistent) Dizziness or lightheadedness Elevated potassium levels Kidney function changes

Read more less